Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells.

Shah MH, Liu GS, Thompson EW, Dusting GJ, Peshavariya HM.

Breast Cancer Res Treat. 2015 Apr;150(3):523-34. doi: 10.1007/s10549-015-3329-z. Epub 2015 Mar 21.

PMID:
25794772
2.

Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.

McInnes LM, Jacobson N, Redfern A, Dowling A, Thompson EW, Saunders CM.

Front Oncol. 2015 Feb 26;5:42. doi: 10.3389/fonc.2015.00042. eCollection 2015. Review.

3.

A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.

Stewart TA, Azimi I, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):509-14. doi: 10.1016/j.bbrc.2015.01.141. Epub 2015 Feb 7.

PMID:
25666946
4.

The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.

Chen A, Wong CS, Liu MC, House CM, Sceneay J, Bowtell DD, Thompson EW, Möller A.

Oncotarget. 2015 Jan 20;6(2):862-73.

5.

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.

Chew GL, Huo CW, Huang D, Blick T, Hill P, Cawson J, Frazer H, Southey MC, Hopper JL, Britt K, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2014 Nov;148(2):303-14. doi: 10.1007/s10549-014-3169-2. Epub 2014 Oct 21.

PMID:
25332094
6.

High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2).

Borrirukwanit K, Pavasant P, Blick T, Lafleur MA, Thompson EW.

Cancer Cell Int. 2014 Oct 3;14(1):99. doi: 10.1186/s12935-014-0099-3. eCollection 2014.

7.

Targeting EMT in cancer: opportunities for pharmacological intervention.

Davis FM, Stewart TA, Thompson EW, Monteith GR.

Trends Pharmacol Sci. 2014 Sep;35(9):479-88. doi: 10.1016/j.tips.2014.06.006. Epub 2014 Jul 16.

PMID:
25042456
8.

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Abubaker K, Luwor RB, Zhu H, McNally O, Quinn MA, Burns CJ, Thompson EW, Findlay JK, Ahmed N.

BMC Cancer. 2014 May 6;14:317. doi: 10.1186/1471-2407-14-317.

9.

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.

Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK, Ahmed N.

Front Oncol. 2014 Apr 9;4:75. doi: 10.3389/fonc.2014.00075. eCollection 2014.

10.

Mammographic density-a review on the current understanding of its association with breast cancer.

Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, Thompson EW.

Breast Cancer Res Treat. 2014 Apr;144(3):479-502. doi: 10.1007/s10549-014-2901-2. Epub 2014 Mar 11. Review.

PMID:
24615497
11.

Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.

Fifis T, Nguyen L, Malcontenti-Wilson C, Chan LS, Nunes Costa PL, Daruwalla J, Nikfarjam M, Muralidharan V, Waltham M, Thompson EW, Christophi C.

Cancer Med. 2013 Oct;2(5):595-610. doi: 10.1002/cam4.109. Epub 2013 Aug 18.

12.

Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.

Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW.

Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.

13.

Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line.

Davis FM, Parsonage MT, Cabot PJ, Parat MO, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Cancer Cell Int. 2013 Jul 29;13(1):76. doi: 10.1186/1475-2867-13-76.

14.

Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time.

Chew GL, Huang D, Huo CW, Blick T, Hill P, Cawson J, Frazer H, Southey MD, Hopper JL, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2013 Jul;140(2):285-97. doi: 10.1007/s10549-013-2642-7. Epub 2013 Jul 24.

PMID:
23881524
15.

Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.

Pinto CA, Widodo E, Waltham M, Thompson EW.

Cancer Lett. 2013 Nov 28;341(1):56-62. doi: 10.1016/j.canlet.2013.06.003. Epub 2013 Jul 2. Review.

PMID:
23830804
16.

Progress in epithelial-mesenchymal transition research.

Newgreen DF, Thompson EW.

Cells Tissues Organs. 2013;197(6):421-3. doi: 10.1159/000351732. Epub 2013 Jun 14. No abstract available.

17.

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K.

Cell Stem Cell. 2013 Jul 3;13(1):117-30. doi: 10.1016/j.stem.2013.05.004. Epub 2013 Jun 13.

18.

Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.

Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW Jr, Goodhill GJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Oncogene. 2014 May 1;33(18):2307-16. doi: 10.1038/onc.2013.187. Epub 2013 May 20.

19.

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.

Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, Thompson EW, Findlay JK, Ahmed N.

Mol Cancer. 2013 Mar 27;12:24. doi: 10.1186/1476-4598-12-24.

20.

Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts.

Purdom E, Restall C, Busuttil RA, Schluter H, Boussioutas A, Thompson EW, Anderson RL, Speed TP, Haviv I.

Genet Res (Camb). 2013 Feb;95(1):14-29. doi: 10.1017/S0016672313000013. Epub 2013 Mar 18.

PMID:
23497823
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk